Kronox Lab Sciences Ltd

BSE: 544187

19

total announcements

544187.BO · 15 min delayed

BSECompany UpdateFundraise4 Sept 2026

Kronox Lab Sciences Ltd

IIFL Capital Services Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Kronox Lab Sciences Ltd ("Target Company").

Kronox Lab Sciences Ltd has received a draft letter of offer from IIFL Capital Services Ltd, the manager to the open offer, regarding an open offer by Indo Borax and Chemicals Limited and Zenrock Chemicals Private Limited to acquire up to 95,70,000 equity shares representing 25.79% of the voting share capital at ₹157.27 per share.

Read more →📎 1 attachment
BSECompany UpdateM&A28 Aug 2026

Kronox Lab Sciences Ltd

Detailed Public Statement ("DPS") has been published by IIFL Capital Services Limited acting as the Manager on behalf of INDO BORAX and Chemicals Limited ("Acquirer") along with Zenrock ....

Kronox Lab Sciences Ltd has announced the publication of a detailed public statement by IIFL Capital Services Ltd on behalf of Indo Borax and Chemicals Ltd and Zenrock Chemicals Private Ltd regarding an open offer to acquire equity shares of Kronox Lab Sciences Ltd.

Read more →📎 1 attachment
BSEAGM/EGMResults24 Aug 2026

Kronox Lab Sciences Ltd

In terms of Regulation 30 of SEBI (LODR) Regulations, 2015 please find enclosed Notice of 17th Annual General Meeting of Shareholders to be held on Wednesday, September 16, 2026.

Kronox Lab Sciences Ltd has announced its 17th Annual General Meeting (AGM) to be held on September 16, 2026, through video conferencing. The meeting will consider and adopt the audited standalone financial statement for the financial year ended March 31, 2026, along with the reports of the Board of Directors and the Auditors. The meeting will also consider a final dividend of Rs. 0.50 per equity share for the financial year 2025-26. Additionally, the meeting will ratify the remuneration payable to the Cost Auditors for the financial year 2026-27.

Read more →📎 1 attachment
BSEOthersResults24 Aug 2026

Kronox Lab Sciences Ltd

Revised Submissoin of Annual Report for the year 2025-26

Kronox Lab Sciences Ltd has revised its submission of Annual Report for the year 2025-26, along with Notice of 17th Annual General Meeting to be held on September 16, 2026, due to a clerical mistake in Event no given by Services provider conducting AGM.

Read more →📎 1 attachment
BSEOthersResults24 Aug 2026

Kronox Lab Sciences Ltd

Anuual Report for the year 2025-26

Kronox Lab Sciences Ltd has submitted its annual report for the year 2025-26, along with a notice of its 17th annual general meeting to be held on September 16, 2026. The company has achieved several milestones, including the commencement of manufacturing at Unit-I, expansion of Unit-I for manufacturing products for pharma and nutraceuticals, and acquisition of land for Unit-II. The company has also obtained FSSC 22000 certification and has listed its stock on NSE & BSE. The financial performance of the company has shown a growth in revenue and profit, with an EBITDA margin of 33.86% and a PAT margin of 25.99% in FY26.

Read more →📎 1 attachment
BSECompany UpdateRegulatory21 Aug 2026

Kronox Lab Sciences Ltd

The Company has received announcement in relation of public offer to the public shareholder of the Company issued by IIFL Capital Services Limited on behalf of Indo Borax & Chemical Limited ....

Kronox Lab Sciences Ltd has received a public announcement from IIFL Capital Services Ltd on behalf of Indo Borax & Chemicals Ltd for an open offer to acquire up to 95.70 lakh equity shares, representing 25.79% of the voting share capital, from public shareholders.

Read more →📎 1 attachment
BSECompany UpdateM&A20 Aug 2026

Kronox Lab Sciences Ltd

IIFL Capital Services Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Public Announcement for the attention of the Public Shareholders of Kronox Lab Sciences Ltd ("Target ....

Kronox Lab Sciences Ltd has received an open offer from Indo Borax and Chemicals Ltd and Zenrock Chemicals Private Ltd to acquire up to 95,70,000 equity shares, representing 25.79% of the voting share capital, from public shareholders.

Read more →📎 1 attachment
BSECompany Update▼ NegativeM&A20 Aug 2026

Kronox Lab Sciences Ltd

Promoters informed the Company about the SPA executed by them with Indo Borax & Chemicals Limited (Acquirer) and Zenrock Chemicals Private Limited (PAC)

Kronox Lab Sciences Ltd has received an intimation from its promoters that they have executed a Share Purchase Agreement (SPA) with Indo Borax & Chemicals Limited and Zenrock Chemicals Private Limited for the sale of 64.26% of the company's equity shares. The acquirer is required to make a mandatory tender offer to public shareholders.

Read more →📎 1 attachment
BSECompany Update▼ NegativeFundraise20 Aug 2026

Kronox Lab Sciences Ltd

Announcement of SPA executed by Promoter with Indo Borax & Chemicals Limited (Acquirer)and Zenrock Chemicals Privated Limited (PAC)

Kronox Lab Sciences Ltd's promoters have executed a Share Purchase Agreement with Indo Borax & Chemicals Limited and Zenrock Chemicals Private Limited for the sale of 2,38,44,000 equity shares, constituting approximately 64.26% of the total paid-up equity share capital of the Company. The transaction is subject to the fulfillment of conditions precedent and other terms as set out in the SPA. The per share price for sale of shares under the SPA is ₹103.22. The Sellers have undertaken certain non-compete and non-solicit obligations for an identified period under the SPA.

Read more →📎 1 attachment
BSEResultResults12 Aug 2026

Kronox Lab Sciences Ltd

Unaudited Financial Results for the quarter ended June 30, 2026

Kronox Lab Sciences Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 28.13 crores, total income at Rs. 30.64 crores, and profit before tax at Rs. 2.53 crores. The company has also appointed M/s. Diwanji & Associates as its cost auditors for the year 2026-27.

Read more →📎 1 attachment
BSEBoard MeetingResults12 Aug 2026

Kronox Lab Sciences Ltd

Board Meeting held today to consider and approve Unaudited Standalone Financial Results for the Quarter ended June 30, 2026 and fix date of AGM and Record Date.

Kronox Lab Sciences Ltd has announced its unaudited standalone financial results for the quarter ended June 30, 2026, and has fixed the date of its 17th Annual General Meeting (AGM) and record date. The company has also appointed M/s. Diwanji & Associates as its Cost Auditors for the year 2026-27.

Read more →📎 1 attachment